Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
BUSINESS ACCOUNT
Sign up for a business account to:
-
Access reports individually or via Subscription
-
Receive monthly invoices with payment via CSA or hard dollars
Get access to other exclusive features
-
Analyst access
-
Free Trial Subscriptions
-
Team account with shared subscriptions
-
Advanced analytics to track research consumption and performance
Bruno Bulic ... (+3)
- Bruno Bulic
- Maria Vara
- Oscar Haffen Lamm
Healthcare Outlook 2025
In our outlook for 2025, we:i) summarise the healthcare market performance in 2024,ii) take a look at ECM, M&A, and private financing trends and,iii) highlight our current conviction ideas for 2025: Abivax, Camurus, Medincell, Egetis, Valneva, Basilea, Onward, Bonesupport and Median.
Antoine Lebourgeois
- Antoine Lebourgeois
Vantiva: strategic refocus through divestiture of SCS
Vantiva has announced the sale of SCS to private equity funds for USD40m. Guidance has been updated to reflect SCS being reclassified under discontinued operations, with EBITDA for ongoing activities (i.e. CH division) now expected to exceed EUR100m, compared to the previous >EUR140m. This align
Antoine Lebourgeois
- Antoine Lebourgeois
Canatu: feedback from roadshow with CEO
Following the roadshow with Canatu's CEO, we summarise the key takeaways. We appreciate the more detailed disclosure, which provides better insight into Canatu's positioning and business model, particularly regarding its semiconductor products. The CEO's in-depth explanation of Canatu's technologic
Maria Vara
- Maria Vara
ONWARD marks commercial breakthrough with FDA green light for ARC-EX
Post-market yesterday, ONWARD announced it has received De Novo FDA approval for ARC-EX Therapy to improve upper limb mobility in SCI patients, meeting both the timeline and positive clearance expectations. This milestone marks the first product launch from ONWARD’s enriched pipeline, aimed at addr
Mahaut Arnaud ... (+3)
- Mahaut Arnaud
- Paul de Froment
- Thomas Mordelle
Waga Energy: EUR12m debt refinancing
Waga Energy yesterday announced that it has secured a EUR12m non-recourse loan with a 13.5 year term from BNP Paribas and Crédit Agricole. This transaction allows Waga Energy to fully refinance four small Wagabox units in France, namely Montois-la-Montagne (15GWh/year), Cusset (17GWh/year), Eteigni
Gregory Ramirez
- Gregory Ramirez
Thibault Morel
- Thibault Morel
Cedric Rossi
- Cedric Rossi
HUGO BOSS: Successful execution and healthy geo mix lead to raised FY2...
HUGO BOSS - NEUTRAL | EUR68 vs. EUR64 Successful execution and healthy geo mix lead to raised FY22 guidance Strong sales and EBIT beat in Q2 driven by execution… … and low exposure to China’s lockdowns FY22 sales and EBIT guidance revised upwards and we increase our FY22-23 estimates by 7%
Clement Genelot
- Clement Genelot